Showing results (111-120 of 160) with videos related to
Sort By:
Pageof 16
AJNR. American Journal of Neuroradiology|May 16, 2025
FDG-PET intensity normalization improves radiomics- based survival prediction in oropharyngeal cancer patients: a comparison of the SUV with alternative normalization techniquesSeyedmehdi Payabvash, Kariem Sharaf, Tal Zeevi, et al.Biorxiv : the Preprint Server for Biology|June 12, 2025
AURKA inhibition amplifies DNA replication stress to foster WEE1 kinase dependency and synergistic antitumor effects with WEE1 inhibition in cancersJong Woo Lee, Jackie Shi, Julian Barrantes, et al.Cephalalgia : an International Journal of Headache|March 9, 2011
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraineDavid J Hewitt, Sheena K Aurora, David W Dodick, et al.The Lancet. Oncology|May 10, 2016
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trialKei Muro, Hyun Cheol Chung, Veena Shankaran, et al.Small (Weinheim an Der Bergstrasse, Germany)|February 20, 2024
Multiplexable and Scalable Aqueous Synthesis Platform for Oleate-Based, Bilayer-Coated Gold NanoparticlesAndreas Backhaus, Jillian Albrecht, Gaukhar Alzhanova, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)Alan L Ho, Nathan R Foster, Alex J Zoroufy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, Nabil F Saba, Denise Roe, et al.Journal for Immunotherapy of Cancer|February 26, 2022
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinomaRobert I Haddad, Tanguy Y Seiwert, Laura Q M Chow, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2019
Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and NeckJong Woo Lee, Janaki Parameswaran, Teresa Sandoval-Schaefer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research GroupShanthi Marur, Shuli Li, Anthony J Cmelak, et al.Pageof 16